Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial

NCT04330690 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

2900

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Artesunate
DRUG: Imatinib
DRUG: Infliximab
DRUG: Dexamethasone
DRUG: LSALT Peptide

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]